Is a patient with chronic liver disease medically fit for planned orthopedic surgery under spinal anesthesia, and what pre‑operative assessments and optimization are required to determine eligibility?

Medical Fitness Assessment for Chronic Liver Disease Patient Undergoing Orthopedic Surgery with Spinal Anesthesia

A patient with chronic liver disease can proceed with orthopedic surgery under spinal anesthesia only if they have compensated cirrhosis (Child-Pugh A with MELD <10-15), no clinically significant portal hypertension, and adequate functional reserve after comprehensive preoperative optimization. 1, 2

Risk Stratification Framework

Determine Disease Severity Using Validated Scores

• Child-Pugh Class A with MELD <10: Surgery is well tolerated with minimal risk 1, 2
• Child-Pugh Class A with MELD 10-15: Surgery permissible with caution; orthopedic procedures are lower risk than intra-abdominal or cardiothoracic surgery 1
• Child-Pugh Class B or MELD >15: High perioperative mortality risk; elective surgery should be deferred 1, 2
• Child-Pugh Class C or Mayo Risk Score >15: Prohibitively high mortality; surgery contraindicated unless life-threatening emergency 1, 2

Assess for Clinically Significant Portal Hypertension (CSPH)

• Perform cross-sectional imaging and upper endoscopy to evaluate for varices, splenomegaly, portosystemic collaterals, and ascites 3
• Presence of CSPH is a relative contraindication even for lower-risk procedures; proceed only after careful multidisciplinary discussion 3
• Absence of both cirrhosis and CSPH: Patient can undergo surgery with minimal risk 1

Mandatory Preoperative Assessments

Cardiovascular Evaluation

• Dobutamine stress echocardiography for patients >50 years, chronic smokers, or those with diabetes/cardiac history to screen for occult coronary disease 3
• Confirm positive stress tests with cardiac catheterization before proceeding, as perioperative mortality is high with undiagnosed coronary disease 3
• Evaluate for cirrhotic cardiomyopathy with baseline echocardiography 3, 4

Pulmonary Assessment

• Screen all patients for hepatopulmonary syndrome with arterial blood gas on room air; PaO₂ <60 mmHg indicates severe disease with ominous prognosis 3
• Doppler echocardiography to screen for pulmonary hypertension; confirm with right heart catheterization if positive 3
• Severe pulmonary hypertension is a contraindication unless effectively controlled with medical therapy 3

Hepatic-Specific Workup

• Laboratory studies: Complete metabolic panel, albumin, bilirubin, INR, platelet count, creatinine clearance 3, 1
• If bilirubin >50 mmol/L (cholestatic disease): Surgery must be postponed until bilirubin drops below this threshold 3, 5
• Abdominal imaging to assess liver morphology, ascites, portal vein patency, and hepatocellular carcinoma 3

Coagulation Status

• Conventional tests (INR, PT, platelet count) do not reliably predict bleeding risk in cirrhosis due to rebalanced hemostasis 2
• Thromboelastography or thrombin generation assays may better reflect true coagulation status 2
• Routine FFP correction of INR does not reduce bleeding risk and increases volume overload/lung injury risk 2

Renal and Metabolic Function

• Calculate creatinine clearance to detect hepatorenal syndrome 3, 1
• Correct electrolyte imbalances and optimize volume status preoperatively 2

Preoperative Optimization Protocol (Minimum 2-4 Weeks)

Nutritional Correction

• Assess for malnutrition (>10% weight loss or >5% over 3 months, low BMI, reduced fat-free mass index) 3
• Provide enteral supplementation for 7-14 days in malnourished patients before surgery 3, 5
• Postpone surgery ≥2 weeks in severely malnourished patients (>10% weight loss) 5

Substance Cessation

• Smoking cessation ≥4 weeks before surgery 3
• Alcohol cessation 4-8 weeks for heavy drinkers (>24 g/day women, >36 g/day men) 3

Ascites Management

• Control ascites with diuretics (spironolactone ± furosemide) to minimize intraoperative complications and reduce postoperative ascitic leak risk 2
• Large-volume paracentesis may be needed immediately preoperatively if tense ascites present 2

Infection Control

• Treat all active infections before surgery, as they precipitate hepatic encephalopathy and worsen liver function 5
• Ensure resolution of any gastrointestinal bleeding 5

Medication Adjustments

• Avoid long-acting anxiolytics (especially in elderly) as they worsen hepatic encephalopathy 3, 5
• Dose-adjust acetaminophen based on extent of hepatic reserve 3, 5
• Consider methylprednisolone 500 mg preoperatively to decrease liver injury (avoid in diabetics) 3, 5

Fasting Protocol

• Limit preoperative fasting to 6 hours for solids and 2 hours for clear liquids 3, 6
• Administer carbohydrate loading the evening before and 2-4 hours before anesthesia to reduce insulin resistance 3, 6

Anesthetic Considerations for Spinal Anesthesia

Advantages of Spinal Over General Anesthesia

• Regional anesthesia uses lower drug doses with less systemic absorption, reducing hepatic drug metabolism burden 7
• Spinal anesthesia avoids hepatotoxic volatile agents and reduces risk of postoperative hepatic decompensation 7
• Valuable for postoperative pain management without relying on hepatically metabolized opioids 8

Specific Precautions

• Coagulopathy assessment is critical: Platelet count should ideally be >50,000/mm³ to minimize epidural hematoma risk 5
• Avoid hypotension: Maintain adequate preload and use vasopressors judiciously, as hepatic blood flow is pressure-dependent 4, 7
• Ensure adequate hydration preoperatively; hypovolemia compounds hepatic hypoperfusion during anesthesia 5
• Use lower local anesthetic doses due to altered pharmacokinetics and increased sensitivity 7

Intraoperative Monitoring

• Close hemodynamic monitoring with arterial line consideration for Child-Pugh B or higher-risk patients 4
• Monitor urine output to detect acute kidney injury early 1

Postoperative Management

Critical Care Admission

• Consider ICU admission for Child-Pugh B, MELD >10, or any patient with significant comorbidities 4

Thromboprophylaxis

• Start low molecular weight heparin or unfractionated heparin postoperatively unless exceptional bleeding risk; add intermittent pneumatic compression devices 3

Monitoring for Complications

• Watch for hepatic decompensation: Worsening ascites, encephalopathy, jaundice, coagulopathy 1, 2
• Monitor renal function closely for hepatorenal syndrome 1
• Early mobilization to reduce thromboembolic risk 3

Absolute Contraindications to Elective Surgery

• Child-Pugh Class C cirrhosis 1, 2
• MELD score >15 (relative; >20 is absolute) 1, 2
• Acute or alcoholic hepatitis 2
• Severe pulmonary hypertension uncontrolled by medical therapy 3
• Severe hepatopulmonary syndrome (PaO₂ <50 mmHg) 3
• Significant extrahepatic organ dysfunction (severe cardiac, renal, or pulmonary disease) 2
• Uncontrolled ascites or active variceal bleeding 2

Common Pitfalls to Avoid

• Do not rely solely on INR for bleeding risk assessment; cirrhotic patients have rebalanced hemostasis 2
• Do not routinely transfuse FFP to "correct" INR; this increases volume overload without reducing bleeding 2
• Do not use NSAIDs postoperatively due to renal toxicity and bleeding risk 3, 2
• Do not assume normal liver function tests mean absence of cirrhosis; imaging and clinical assessment are essential 1
• Do not proceed with emergency surgery without attempting conservative management first in high-risk patients 2